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Abstract
Background: The Ergp55 protein belongs to Ets family of transcription factor. The Ets proteins are highly conserved in their
DNA binding domain and involved in various development processes and regulation of cancer metabolism. To study the
structure and DNA binding autoinhibition mechanism of Ergp55 protein, we have produced full length and smaller
polypeptides of Ergp55 protein in E. coli and characterized using various biophysical techniques.
Results: The Ergp55 polypeptides contain large amount of a-helix and random coil structures as measured by circular
dichorism spectroscopy. The full length Ergp55 forms a flexible and elongated molecule as revealed by molecular modeling,
dynamics simulation and structural prediction algorithms. The binding analyses of Ergp55 polypeptides with target DNA
sequences of E74 and cfos promoters indicate that longer fragments of Ergp55 (beyond the Ets domain) showed the
evidence of auto-inhibition. This study also revealed the parts of Ergp55 protein that mediate auto-inhibition.
Significance: The current study will aid in designing the compounds that stabilize the inhibited form of Ergp55 and inhibit
its binding to promoter DNA. It will contribute in the development of drugs targeting Ergp55 for the prostate cancer
treatment.
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Introduction
The Ets family proteins share highly conserved winged helix-
turn-helix DNA-binding domain and bind to consensus DNA core
sequence 59-GGA (A/T)-39 [1]. The Erg proteins belong to Ets
family of transcription factor. Erg gene is rearranged in human
myeloid leukemia [2] and in 5–10% of patients with Ewing’s
sarcoma [3]. In both cases, chromosomal translocations results in
the expression of oncogenic fusion proteins composed of Erg and
member of Tet subfamily of RNA binding proteins. Erg protein is
essential for definitive hematopoiesis, adult hematopoietic stem cell
function and maintenance of normal peripheral blood platelet
numbers [4]. The TMPRSS2-Erg fusion oncogene transcripts
observed in prostate cancer cells are significantly associated with
aggressive cancer, metastatic spread and increased probability of
death [5].
The Erg gene encodes five proteins, Erg-1, Erg-2, Ergp55,
Ergp49 and Ergp38 as a result of different splicing, polyadenyl-
ation or initiation codon. The Ergp55 isoform contains four
functional domains, which are involved in DNA binding,
transcriptional activation and negative regulation of transactiva-
tion [6]. The Ergp55 protein forms dimer with itself and with two
other isoforms Ergp49 and Ergp38, via PNT and Ets domain [7].
The central domain of Ergp55 behaves as inhibitory domain on
dimerization and its removal enhances the transactivation
property (7). The critical residues of Ets domain of Ergp55, which
mediate Ergp55-jun/fos-DNA ternary complex formation, have
been identified and characterized [8].
So far, tertiary structure of any full-length Ets protein is not
determined. However, structures of DNA-binding domains of
several Ets proteins have been determined using X-ray crystallog-
raphy and nuclear magnetic resonance techniques [9–16]. The
gonome-wide analysis of Ets-family DNA-binding in vitro and in
vivo has been studied recently [17].
The precise mechanism by which, Ergp55 protein acts on
transcription is not understood. To understand the structure and
DNA binding autoinhibition mechanism of Ergp55, we performed
circular dichorism, molecular modeling and theoretical structural
prediction analysis on Ergp55 polypeptides. To understand the
DNA binding autoinhibition mechanism, the binding studies of
Ergp55 polypeptides with DNA sequences of E74 and cfos
promoters were carried out. Our results indicated that (i) Ergp55
polypeptides contains high percentage of a-helix and random coil
structures (ii) full length Ergp55 is a flexible and elongated
molecule (iii) longer fragments beyond the canonical Ets domain of
Ergp55 showed the evidence of autoinhibition.
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Construction of Ergp55 plasmids
The full length Erg1–479 and Erg112–399 genes were cloned in
pET28a (+) vector. The Erg1–399 and Erg307–399 genes were cloned
in pRSETA and pET21a (+) expression vector. All deletion
mutant genes were amplified from full-length Erg1–479 plasmid
using polymerase chain reaction.
Purification of Ergp55 polypeptides
The Erg1–479, Erg1–399, Erg112–399 and Erg307–399 plasmids were
transformed into E. coli. BL21 (DE3) cells. The cells were grown in
3 liters luria bertani media containing appropriate antibiotics at
37uC, until OD600 reached to 0.6. The 0.125 mM IPTG was
induced at 37uC and culture further shaked for 4 h at 220 rpm.
The cells were harvested by centrifugation at 6000x g for 10umin
at 4uC. The cells were suspended in 50 ml of lysis buffer
containing (25 mM Tris-HCl pH 8.0, 300 mM NaCl, 1 mM
benzamidine-HCl, 0.1% triton X-100, 5% glycerol, 3 mM 2-
mercaptoethanol, 1 mM phenylmethylsulfonyl fluoride and
0.5 mg/ml lysozyme) and disrupted by sonication at 4uC. The
crude lysate was centrifuged at 250006g for 20 min at 4uC. The
supernatant was loaded on Ni-NTA column, pre-equilibrated with
binding buffer (25 mM Tris-HCl pH 8.0, 300 mM NaCl, 1 mM
benzamidine-HCl, 5% glycerol, 2 mM 2-mercaptoethanol, 1 mM
phenylmethylsulfonyl fluoride and 10 mM imidazole). The pro-
teins were eluted from column with elution buffer (25 mM Tris-
HCl pH 8.0, 300 mM NaCl, 1 mM benzamidine-HCl, 5%
glycerol, 3 mM 2-mercaptoethanol, 1 mM phenylmethylsulfonyl
fluoride and 250 mM imidazole). The eluted fractions were
pooled, concentrated and loaded on Sephacryl S-200 HR gel-
filtration column pre-equilibrated in buffer (25 mM Tris-HCl
pH 8.0, 150 mM NaCl, 3 mM 2-mercaptoethanol and 5%
glycerol). The purified proteins were concentrated to 10 mg/ml
using amicon ultra centrifugal filter device (Mw cutoff, 10 kD).
The protein concentration was measured by UV radiation at
280 nm by using extinction coefficient calculated with EXPASY
software (http://us.expasy.org/tools/protparam.html).
N-terminal protein sequencing and ion spray mass spectrometry
confirmed identity and purity of Ergp55 polypeptides. Protein
Figure 1. The human Ergp55 protein sequence. (A) Shown here the amino acid sequences full length Ergp55 without 6xHis tag and cleavage
site. The residues were highlighted according to the size of Ergp55 domains, NTD (yellow), PNT (green), CAE/CD (blue/cyan), Ets (red) and CTD (black).
(B) Shown here the Ergp55 constructs used in the experiments (coloring scheme same as in Fig. 1A). The labeled residues defining the sequence of
beginning and end of constructs. Aestericks denote the position of 6xHis tag on various Ergp55 constructs.
doi:10.1371/journal.pone.0039850.g001
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Coomassie brilliant blue stained SDS-PAGE analysis indicated
that all Ergp55 polypeptides were purified greater than 95%
purity. All proteins were stored at 220uC.
Surface plasmon resonance experiment
Biosensor studies were performed using BIAcore 2000 (Biacore
Pharmacia Biosensor AB, Uppsala Sweeden) equipment [18]. All
experiments were performed at 25uC in HBS-buffer containing
[10 mM HEPES buffer pH 7.4, 150 mM NaCl, 50 mM EDTA,
0.005% P20 as surfactant). Since all Ergp55 polypeptides contain
6xHis tag either on N- or C-terminal, the sensor chip containing
high density of immobilized Ni-NTA is an ideal tag to immobilize
these proteins. Initially, the flow cells of the chip were activated by
passing nickel chloride solution over it. 40 ul of each Ergp55
polypeptide e.g., Erg1–479 (0.14 ug/ul), Erg1–399 (0.19 ug/ul),
Erg112–399 (0.92 ug/ul) and Erg307–399 (0.17 ug/ul) were injected
in different flow cells of Ni-NTA chip at flow rate of 10 ul/min.
In different flow cells of Ni-NTA chip, following RU unit of
each Ergp55 polypeptide was immobilized e.g., Erg1–479 (2904
RU), Erg1–399 (2848 RU), Erg112–399 (2825 RU) and Erg307–399
(247 RU), where 1 RU corresponds to immobilized protein of
concentration ,1 pg/mm. Binding experiments were performed
with three different concentration [1, 2, 3 mM) of DNA sequence
Figure 2. Size exclusion chromatography of Ergp55 polypeptides. The chromatogram of (A) full length Erg1–479 (B) Erg1–399 (C) Erg112–399 and
(D) Erg307–399 polypeptides are shown. The SDS-PAGE analysis and calculated molecular weight of each protein are denoted on each chromatogram.
doi:10.1371/journal.pone.0039850.g002
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injected over immobilized Ergp55 polypeptides at flow rate of
10 ml/min. Similar experiment was performed using DNA
sequence of cfos promoter sequence (59 GACAGGATGTG 39).
The sensogram allowed to run for another 4 min. The regener-
ation of biosensor surface was done using 30 s pulse of 1 mM
NaOH at flow rate of 10 ml/min. Associate and dissociation
kinetic constants were calculated by BIAeveluation 3.0 software
using simple 1:1 Langmuir model with the assumption, that
density of Ergp55 polypeptides on the sensor chip were not high
enough to support bivalent DNA binding.
Circular dichorism
CD measurements were recorded using Chirascan
TM CD
spectropolarimeter (Applied Photophysics) with a water bath to
maintain the constant temperature. The Ergp55 polypeptides were
diluted to 0.2 mg/ml in 10 mM sodium phosphate buffer, pH 8.0
and loaded on 0.1 cm quartz cuvette. The blank of all experiments
was 10 mM sodium phosphate buffer, pH 8.0. The final spectrum
was an average of three sequential scan.
For thermal denaturation study of full length Ergp55, the CD
spectra were recorded at 10uC increment starting from 10uCt o
90uC. Before measurement, the sample cuvette was equilibrated at
each temperature. Temperature readings were taken within
cuvette holder agreed with temperature of water bath. All CD
data were converted to mean residue ellipticity (deg. cm
2/dmol).
The Dichroweb server [19] was used to estimate the amount of
secondary structure in Ergp55 polypeptides from CD spectra.
Secondary structure prediction
The SOPMA [20], GOR [21] and PSIPRED [22] algorithms
were used to predict the secondary structure contents in full length
Ergp55, which showed ,21% a-helix, 12–15% b-sheet and 65–
69% random coil structures.
Modeling of Ergp55 polypeptides
Phyre server [23] was used to obtain the structure of full length
Ergp55 protein (1–479 residues). The server yielded the structure
of PNT domain (95–221 residues) of Ergp55 using template PDB-
2YTU (solution structure of SAM-PNT domain of human friend
leukemia integration factor-1 transcription factor, not yet
published). The NMR solution structure of PNT domain (108–
201 residues) was obtained from protein data bank (PDB-1SVO)
[24]. The Phyre server also yielded the structure of Ets domain
(284–412 residues) of Ergp55 using the template PDB-2NNY
(Regulation of transcription factor Ets-1 by DNA mediated
Figure 3. Binding analysis of DNA sequence of E74 promoter to immobilized Ergp55 polypeptides. In figures (A) Erg1–479 (B) Erg1–399 (C)
Erg112–399 and (D) Erg307–399 polypeptides were immobilized on Ni-NTA chip. Three concentration (1, 2, 3 mM) of DNA sequence of E74 promoter
injected on each immobilized Ergp55 polypeptide.
doi:10.1371/journal.pone.0039850.g003
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Fli1 (306–403 residues) was obtained from protein data bank
(PDB-1FliA) [25]. The structural modeling of N- terminal (1–94
residues), central domain (222–283 residues) and C- terminal
(413–479 residues) of Ergp55 were not attempted due to lack of
input model.
The Modeler [26] and LOMETS threading [27] programs
were used to build the structure of full length Ergp55 using
following inputs (i) structural model of PNT domain (95–221
residues) of Ergp55 (ii) structural model of Ets domain (284–412
residues) of Ergp55 (iii) NMR structure of PNT domain (108–201
residues) of Ergp55 and (iv) NMR structure of Ets domain (306–
403 residues) of Fli1. Energy minimization was performed on
modeled Ergp55 using Gromacs program version 4.0.5 [28]. 100
steps of steepest decent and 500 steps of conjugated gradient
algorithms were used in energy minimization calculation.
Molecular dynamics simulations
The 10 ns molecular dynamics (MD) simulation was performed
on minimized Ergp55 model using GROMACS program (version
4.0.5) with Gromacs43a2 force field [28]. The Ergp55 model was
immersed in a cubic box extending 0.5 nm from the protein
surface and solvated with explicit SPC water molecules. Chloride
and sodium ions were added to neutralize the systems, which were
then simulated with periodic boundary conditions. The solvated
Ergp55 model consists of 4832 protein atoms surrounded by
,390, 000 water molecules. Before running the simulation, whole
system was energy minimized for 200 iterations of steepest
descents and then equilibrated for 20 ps keeping protein atoms
restrained. All restraints were removed from the protein and
temperature was gradually increased in 10 distinct steps of 5 ps
simulations each.
Berendsen coupling was employed to maintain a constant
temperature of 300 K with a coupling constant t of 0.1 ps. Van
der Waals interactions were modeled using 6–12 Lennard-Jones
potentials with 1 nm cutoff. The coulomb cut off was 1.0. The
time step employed was 2 fs and coordinates were saved every 5 ps
for analysis of MD trajectories.
The stereochemistry of simulated Ergp55 model was checked by
PROCHECK program of CCP4 suite [29]. Secondary structure
composition was measured by DSSP program [30] and structure
visualization by PyMOL program [31].
Figure 4. Binding analysis of DNA sequence of cfos promoter to immobilized Ergp55 polypeptides. In figures (A) Erg1–479 (B) Erg1–399 (C)
Erg112–399 and (D) Erg307–399 polypeptides are immobilized on Ni-NTA chip. Three different concentration (1, 2, 3 mM) of DNA sequence of cfos
promoter injected on each immobilized Ergp55 polypeptide.
doi:10.1371/journal.pone.0039850.g004
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Purification of recombinant Ergp55 polypeptides
We produced full length and smaller polypeptides (containing
subset of predicted domains) of Ergp55 in E. coli and purified using
standard chromatographic techniques (Fig. 1A–B). During size
exclusion chromatography, the purified Erg1–479, Erg1–399, Erg112–
399 and Erg307–399 polypeptides eluted at volumes corresponding
to their molecular weights (Fig. 2A–D). The full length Erg1–479
eluted at the size of 53.8 kD, Erg1–399 polypeptide eluted at
51.1 kD, Erg112–399 eluted at 44.9 kD and Erg112–399 eluted at
15.1 kD. The Erg1–479 and Erg1–399 polypeptides have tendency to
degrade if kept for 7 days at 4uC. The Erg112–399 and Erg307–399
polypeptides do not degrade over time and more stable than Erg1–
479 and Erg1–399 polypeptides.
DNA binding studies using E74 and cfos promoter
sequences
The functionality of purified Ergp55 polypeptides was assessed
by DNA binding experiment using surface plasmon resonance
technique. The observed KD value of Ergp55 polypeptides with
DNA sequence of E74 promoter were e.g., Erg1–479 , 704 nM,
Erg1–399 , 217 nM, Erg112–399 , 115 nM and Erg307–399 ,
65 nM (Fig. 3A–D). These results indicated that Ets domain of
Ergp55 (Erg307–399) has the highest affinity for E74 promoter DNA
sequence. The DNA binding affinity decreases , 2 fold for Erg112–
399 polypeptide, ,3 fold for Erg1–399 polypeptide and ,10 fold for
full-length Erg1–479, when compared with Erg307–399 polypeptide
(Ets domain). These results indicate that N- as well as C- terminal
domains with respect to Ets domain are involved in auto-inhibition
of DNA binding to Ergp55 protein.
The observed KD value of Ergp55 polypeptides with cfos
promoter sequence were e.g., Erg1–479 , 232 mM, Erg1–399 ,
196 mM, Erg112–399 , 38 mM and Erg307–399 , 0.45 mM (Fig. 4A–
D). These results also indicate that Ets domain has the highest
affinity for DNA sequences of cfos promoter. Both N- and C-
terminal domains with respect to Ets domain are involved in
inhibition of cfos DNA binding to Ergp55 protein.
CD measurements of Ergp55 polypeptides
To identify the secondary structure contents in Ergp55
polypeptides, the far-UV CD spectroscopy was used (Fig. 5A).
The CD data were de-convoluted using DICHROWEB web
server [19] and percentage of a-helix, b-sheet and random coil
structures were estimated. The CD spectra of full-length Erg1–479
(Fig. 5A) showed two minima around 208 nm and 222 nm, a
characteristic of a-helical structure. Deconvolution of data predicts
,35% a-helix, 15% b-sheet and 49% random coil structures in
full length Ergp55. The CD data of Erg1–399 polypeptide predicts
,25% a-helix, 17% b-sheet and 57% random coil structures,
which shows less a-helix and b-sheet structure compare to full
length Erg1–479 structure.
In case of Erg112–399 polypeptide, the CD data estimates ,29%
a-helix, 15% b-sheet and 55% random coil structures. This
polypeptide contains less a-helix, similar b-sheet structure
compared to full length Erg1–479. For Erg307–399 polypeptide, the
CD data estimates ,31% a-helix, 10% b-sheet and 59% random
coil structures, which has less a-helix and b-sheet structure
compare to full length Erg1–479 structure. However, these values
are close to secondary structure contents in crystal structure of Ets
domain of Fli-1 (35.7% a-helix, 4.1% b-sheet, 60.2% random
coil). The Ets domain of Fli-1 is the closest homologous to Ets
domain of Ergp55 [32].
Thermostability of full length Ergp55
To assess the thermostability of full length Ergp55, a far UV-
CD spectrum of protein was measured from 10 to 90uC (Fig. 5B).
It is clear from spectra that secondary structure of Ergp55
denatures as temperature increased. When mean residue ellipticity
at 222 nm is plotted against temperature, the inflection point of
sigmoidal curve indicates the Tm of 4562uC of full length Ergp55.
Molecular modeling and dynamic simulation of full
length Ergp55
The secondary structure prediction on full length Ergp55 using
PSIPRED program is shown in (Fig. 6A). The Modeler and
automatic threading LOMETS programs were used to construct
full length Ergp55 model using (i) structure of 95–221 residues of
Figure 5. CD spectra of Ergp55 polypeptides. (A) CD spectra of Erg1–479, Erg1–399, Erg112–399 and Erg307–399 polypeptides recorded from 200 nm
to 260 nm. (B) Temperature induced unfolding of full length Ergp55 protein. The plot (inner) containing mean residue ellipticity versus temperature
indicates the denaturation of a-helices of folded full length Ergp55.
doi:10.1371/journal.pone.0039850.g005
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57% sequence identity (ii) the structure of 284–412 residues of
Ergp55 using template PDB-2NNY [13] having 40% sequence
identity and (iii) NMR structure of 108–201 residues of Ergp55
and (iv) NMR structure of 306–403 residues of Ets domain of Fli-1
having 90% sequence identity. Energy minimization and dynam-
ics simulations analysis were performed on constructed Ergp55
model, which yielded a flexible and elongated structure (Fig. 6B).
The Ergp55 structure remained very stable during whole
simulation time, as confirmed by all the indicators commonly
used to analyze MD simulation.
The 93% residues of Egp55 model lie in most favored region of
Ramachandran plot and a Prosa Z-score of 24.87. DISOPRED
[33] analysis on Ergp55 model indicated that N-terminal (1–118
residues) and C-terminal (397–479 residues) are largely disordered
(except N-terminal 4–23 residues) and remaining Ergp55 structure
(119–396 residues) were ordered (Fig. 6C). The structured PNT
domain contains tertiary arrangement of four a-helices, charac-
teristic of large group of SAM domain [34]. The Ets domain
consists of four a-helices and fourb-sheets, a characteristic of Ets
family proteins. In N-terminal domain, 15 residue stretch
predicted to form a-helix and 3 residue long helix (219–221
residues) are observed in in CAE/CD domain of Ergp55. The
stretches of residues in C-terminal domain of Ergp55 predicted to
have only random coil structure.
The N- terminal and C-terminal domain of Ergp55 are
positioned away from Ets domain. The DNA binding groove of
Ets domain is exposed to solvent and free to bind promoter DNA
sequences. The CAE/CD domain is positioned between PNT and
Ets domain to regulate the activity of Ergp55. The N- terminal
and C-terminal domains of Ergp55 are positioned in a region that
do not prevent the DNA binding activity of Ets domain and play a
role in transcriptional activation and localization of Ergp55.
Discussion
In current study, we have expressed full length and smaller
polypeptides of Ergp55 in E. coli. The combinations of two
chromatography steps (Ni-NTA affinity and size exclusion
Figure 6. Model of Ergp55 polypeptides. (A) PSIPRED program analysis of full length Ergp55. (B) Structural model of full length Ergp55 after
molecular modeling and dynamics simulation analysis using GROMACS program (C) The disordered prediction made by DISOPRED for (a), NTD (b),
PNT (c), CAE/CD (d), ETS and (e), CTD regions of Ergp55.
doi:10.1371/journal.pone.0039850.g006
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polypeptides based on mass spectrometry and SDS-PAGE
analysis. Prior to structural studies, the activity of purified Ergp55
polypeptides were checked by binding studies using DNA
sequences of E74 and cfos promoters. The surface plasmon
resonance technique was used for binding analysis. These results
indicated that Ergp55 polypeptides produced in E. coli were in
good conformation and bind specifically DNA sequences of E74
and cFos promoters with different affinities.
DNA binding autoinhibition of Ergp55. In case of E74
promoter sequence, following KD values were observed for Ergp55
polypeptides (i) Erg307–399, 65 nM (ii) Erg112–399, 115 nM (iii)
Erg1–399, 217 nM and (iv) full length Erg1–479, 704 nM. Compar-
ison of (i) and (ii) indicated that N-terminal region (PNT+CAE/
CD domains) preceding to Ets domain inhibit the E74 DNA
binding to Ets domain. Comparison of (ii) and (iii) showed the
evidence of increased DNA binding inhibition by having NTD
domain in Erg1–399 polypeptide. Comparison of (iii) and (iv)
indicate that adding CTD domain in Erg1–399 polypeptide showed
enhanced inhibition in DNA binding to Ets domain. These results
indicate that E74 DNA binding to Ergp55 is negatively influenced
by CAE/CD, PNT and NTD domains located at N-terminal and
CTD domain located C-terminal region in Ergp55.
With cfos promoter DNA sequence, following KD values were
obtained for Ergp55 polypeptides (i) Erg307–399, 0.4 mM (ii) Erg112–
399, 37 mM (iii) Erg1–399, 196 mM and (iv) full length Erg1–479,
232 mM. These results indicate that cfos promoter sequence bind
with different affinity to Ergp55 polypeptides than E74 promoter
sequence, however mechanism of DNA binding inhibition was
similar as observed in case of E74 promoter DNA sequence.
A cooperatively acting DNA inhibiting region (468–510
residues) was identified at C-terminal of Ets-1 transcription factor
[34]. In case of ERM and PEA3 transcription factors, two main
domains located at N- and C-terminal with respect to their ETS-
domain inhibiting DNA binding affinity [35–38]. One domain
corresponds to residue 280–360 residues of ERM transcription
factor, involved in inhibition of ERM DNA binding capacity.
These domains are rich in proline residues generally devoid a-
helical structures. The mechanism by which two domains
cooperatively inhibit ERM DNA binding is different than
observed in case of Ets-1 transcription factor. The DNA binding
activity of Ets domain is dependent on autoinhibitory module [39].
The binding affinity of Ets domain Ergp55 to E74 and cfos
promoter DNA was consistent to the observation obtained in case
of above transcription factors.
Circular dichorism analysis of Ergp55
polypeptides. The circular dichorism technique was used to
identify the secondary and tertiary structures of Ergp55 polypep-
tides. The full length and smaller Ergp55 polypeptides contain
high a-helical and random coil structures. The CD data estimates
35% a-helix and 49% random coil structures in full length Ergp55
protein. Examinations of thermal stability and temperature effect
on full length Ergp55 protein indicated that protein underwent an
alteration of secondary structure upon heating. The secondary
structure is regained after cooling the protein from 80uCt o2 0 uC.
Short change of temperature is unlikely to have any effect on
secondary structure of Ergp55 protein.
Modeling and dynamics simulation of full length
Ergp55. The molecular modeling and dynamics simulation
analysis indicated that full length Ergp55 acquires a flexible and
highly elongated structure. Only PNT and Ets domains are
structured in protein and long flexible regions are observed at N-
and C- terminus of Ergp55. The structure of PNT domain of
Ergp55 consists of four-helix bundle Sam like structure (34). The
Ets domain of Ergp55 is structured in a winged helix-turn-helix
with scheme a1b1b2a2a3b3b4a4 [40–41]. The central CAE/CD
domains contain one small helix at position 220. The secondary
and disordered prediction analysis on Ergp55 also supported the
finding observed in modeling and dynamics simulation studies of
Ergp55. All these observations supported the flexible, non-
globularity and highly elongated structure of Ergp55 protein.
In conclusion, we have characterized the recombinant full
length and smaller polypeptides of Ergp55 produced in E. coli. The
Ergp55 polypeptides were purified greater than 95% purity as
determined by mass spectrometry and SDS-PAGE analysis. The
structural data presented here showed the evidence of flexible and
highly elongated structure of full length Ergp55 protein. The
binding analysis using DNA sequences of E74 and cfos promoters
indicate that longer fragments of Ergp55 (beyond the canonical
Ets domain) showed the evidence of autoinhibition.
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